Market revenue in 2023 | USD 3,377.3 million |
Market revenue in 2030 | USD 5,808.5 million |
Growth rate | 8.1% (CAGR from 2023 to 2030) |
Largest segment | Transdermal patches |
Fastest growing segment | Drug Eluting Stents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 23.05% in 2023. Horizon Databook has segmented the Italy drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
Italy’s aging population and the growing proportion of individuals aged over 65 are some of the key factors expected to drive the drug device combination products market growth. This demographic shift is significant as older adults often suffer from chronic diseases that require long-term medication adherence.
According to the Italian Institute for International Political Studies, Italy is experiencing rapid population aging, with 37 people older than 65 per every 100 working-age individuals in 2022, which is projected to rise to 65 by 2050. In addition, the share of people over 80 years is expected to increase from 3.7% to 7.5% during the same period, emphasizing the need for effective drug delivery mechanisms to address the healthcare needs of the elderly.
Moreover, the competition is fueled by the increasing number of surgeries linked to heart and respiratory failure performed across a range of medical specialties in Italy, as well as the increased emphasis on innovative surgical techniques.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into Italy drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account